title: Bakri balloon effectiveness for postpartum hemorrhage: a "real world experience".
abstract: BACKGROUND
  The Bakri balloon has been advocated for management of obstetric hemorrhage, based on several small studies (2-16 patients) where it was over 90% effective.
  
  
  OBJECTIVE
  To estimate the effectiveness of the Bakri balloon for treating postpartum hemorrhage (PPH) in clinical practice at academic institutions.
  
  
  METHODS
  This is a retrospective cohort study evaluating efficacy of Bakri balloon use in 35 women with PPH, performed as a chart review. Charts were reviewed to determine if balloon placement was deemed a "success" or "failure", as well as to abstract relevant demographic and clinical factors. Failure was defined as need for another form of hemorrhage control.
  
  
  RESULTS
  Success rate was 67.57%. Bakri failure was associated with Cesarean section (67% versus 16%, p = 0.031) and predelivery Pitocin (67% versus 28%, p = 0.003) and had more ICU admissions (58% versus 4%, p = 0.0003), transfusions (5.4 red blood cell units versus 1.6, p = 0.007) and hospital days (5.65 versus 3.75, p = 0.011). Reasons for failure were continued bleeding or balloon extrusion.
  
  
  CONCLUSIONS
  Our results suggest that the Bakri balloon is useful for treating PPH but not as effective as previously published. When balloon use is effective, however, the maternal morbidity is significantly decreased.
authors.affiliation: Department of Obstetrics and Gynecology, University of Washington , Seattle , WA, USA .
authors.forename: Richelle
authors.initials: R
authors.lastname: Olsen
authors.forename: Dale P
authors.initials: DP
authors.lastname: Reisner
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Benedetti
authors.forename: Rebecca F
authors.initials: RF
authors.lastname: Dunsmoor-Su
mesh_terms: D000328:Adult; D021721:Balloon Occlusion / Q000009:adverse effects / Q000295:instrumentation* / Q000379:methods*; D002585:Cesarean Section / Q000009:adverse effects / Q000706:statistics & numerical data; D004868:Equipment Failure / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D007751:Labor, Induced / Q000009:adverse effects / Q000706:statistics & numerical data; D010120:Oxytocics / Q000009:adverse effects; D010121:Oxytocin / Q000009:adverse effects; D006473:Postpartum Hemorrhage / Q000453:epidemiology / Q000628:therapy*; D011247:Pregnancy; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D010120:Oxytocics; D010121:Oxytocin